The International Consortium for Health Outcomes Measurement assembled an international working group of venous thromboembolism experts and patient representatives to develop a standardised minimum set of outcomes and outcome measurements for integration into clinical practice and potentially research to support clinical decision making and benchmarking of quality of care. 15 core outcomes important to patients and health-care professionals were selected and categorised into four domains: patient-reported outcomes, long term consequences of the disease, disease-specific complications, and treatment-related complications. The outcomes and outcome measures were designed to apply to all patients with venous thromboembolism aged 16 years or old...
Aims: Congenital heart disease (CHD) is the most common congenital malformation. Despite the worldwi...
Aims: Congenital heart disease (CHD) is the most common congenital malformation. Despite the worldwi...
: The global annual incidence of venous thromboembolism (VTE) is estimated to be 0.75-2.69 per 1,000...
The International Consortium for Health Outcomes Measurement assembled an international working grou...
The International Consortium for Health Outcomes Measurement assembled an international working grou...
Introduction Venous thromboembolism (VTE) is a common, potentially fatal yet treatable disease. Seve...
INTRODUCTION The development of a core outcome set (COS), defined as an agreed minimum set of out...
The main objectives of therapeutic trials in venous thromboembolism (VTE) are to prevent recurrent V...
Aims: As health systems around the world increasingly look to measure and improve the value of care ...
Clinical research in venous thromboembolism (VTE) is hindered by variability in the collection and r...
Background: The objective of this thesis was to identify a list of outcomes to consider in the devel...
INTRODUCTION Venous thromboembolism (VTE) is a common, potentially fatal yet treatable disease. S...
Introduction: We recently proposed a scale for assessment of patient-relevant functional limitations...
Aims: Congenital heart disease (CHD) is the most common congenital malformation. Despite the worldwi...
Aims: Congenital heart disease (CHD) is the most common congenital malformation. Despite the worldwi...
: The global annual incidence of venous thromboembolism (VTE) is estimated to be 0.75-2.69 per 1,000...
The International Consortium for Health Outcomes Measurement assembled an international working grou...
The International Consortium for Health Outcomes Measurement assembled an international working grou...
Introduction Venous thromboembolism (VTE) is a common, potentially fatal yet treatable disease. Seve...
INTRODUCTION The development of a core outcome set (COS), defined as an agreed minimum set of out...
The main objectives of therapeutic trials in venous thromboembolism (VTE) are to prevent recurrent V...
Aims: As health systems around the world increasingly look to measure and improve the value of care ...
Clinical research in venous thromboembolism (VTE) is hindered by variability in the collection and r...
Background: The objective of this thesis was to identify a list of outcomes to consider in the devel...
INTRODUCTION Venous thromboembolism (VTE) is a common, potentially fatal yet treatable disease. S...
Introduction: We recently proposed a scale for assessment of patient-relevant functional limitations...
Aims: Congenital heart disease (CHD) is the most common congenital malformation. Despite the worldwi...
Aims: Congenital heart disease (CHD) is the most common congenital malformation. Despite the worldwi...
: The global annual incidence of venous thromboembolism (VTE) is estimated to be 0.75-2.69 per 1,000...